FDA Approves Roche PTEN Assay for Prostate Cancer Protein Deficiency
Roche announced that the Food and Drug Administration (FDA) approved the Ventana PTEN (SP218) RxDx Assay, an immunohistochemistry…
Roche wins FDA nod for PTEN-loss prostate test
Roche (OTCQX:RHHBY) received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the…
Roche VENTANA MMR RxDx Panel Gains EU IVDR Approval for Multiple Cancers
Roche has received European Union In Vitro Diagnostic Regulation approval for several label expansions of its VENTANA MMR…